Research Article
Classification and Drug Resistance Analysis of Pathogenic Bacteria in Patients with Bacterial Pneumonia in Emergency Intensive Care Unit
Table 5
Resistance analysis of major G− bacteria.
| | <!—Col Count:5Antibacterial agents | Acinetobacter baumannii, Klebsiella pseudomonas, Escherichia coli, and Pneumoniae aeruginosa | | (N = 108) | (N = 53) | (N = 35) | (N = 20) | | The number of drug-resistant bacteria (N (%)) | The number of drug-resistant bacteria (N (%)) | The number of drug-resistant bacteria (N (%)) | The number of drug-resistant bacteria (N (%)) |
| | Cefoperazone/sulbactam | 34 (31.48) | 24 (45.28) | 4 (11.43) | 11 (55.00) | | Piperacillin/tazobactam | 81 (75.00) | 31 (58.49) | 5 (14.29) | 12 (60.00) | | Ceftazidime | 87 (80.56) | 29 (54.72) | 6 (17.14) | 17 (85.00) | | Imipenem | 73 (67.59) | 12 (22.64) | 9 (25.71) | 18 (90.00) | | Levofloxacin | 84 (77.78) | 8 (15.09) | 8 (22.85) | 10 (50.00) | | Amikacin | 77 (71.30) | 2 (3.77) | 2 (5.71) | 6 (30.00) | | Ciprofloxacin | 85 (80.95) | 7 (13.21) | 6 (17.14) | 3 (15.00) | | Gentamicin | 83 (76.85) | 3 (5.66) | 4 (11.43) | 15 (75.00) | | Polymyxin B | 12 (11.11) | — | — | — | | Minocycline | 10 (9.26) | — | — | 2 (10.00) | | Tegacyclin | 5 (4.63) | — | — | 1 (5.00) |
|
|
